Cancer News and Research

Latest Cancer News and Research

Vanderbilt researchers find link between the biological clock and Angelman syndrome

Monitoring participants' biological clocks may be the quickest way to determine the effectiveness of experimental drugs currently under development to treat Angelman syndrome: a debilitating genetic disorder that occurs in more than one in every 15,000 live births.

6 Feb 2015

Bright Pink and David's Bridal team up to educate women on breast and ovarian cancer

As the nation's leading bridal and special occasion authority, David's Bridal is honored to outfit a woman for the many milestones in her life, most notably her wedding day.

6 Feb 2015

Study examines use of yoga therapy to address lymphedema

Cancer is bad enough. But cancer patients who receive surgery, radiation and chemotherapy may suffer from side effects that run from irritating to crippling — problems that are postural, musculoskeletal and respiratory, along with lowered self-esteem. Many suffer from lymphedema, swelling caused by retained fluid in a compromised lymphatic system.

6 Feb 2015

Study shows that text messages could improve skin cancer prevention, promote sun protection

Australians' love affair with mobile phones could save their life according to a joint QUT, Cancer Council Queensland and University of Queensland study using text messages to improve skin cancer prevention and promote sun protection.

6 Feb 2015

Chemotherapy or immunosuppressive treatment may reactivate HBV

Individuals previously infected with the hepatitis B virus (HBV) who receive chemotherapy or immunosuppressive treatment may be at risk of reactivating the disease according to a summary of report from the Emerging Trends Conference, "Reactivation of Hepatitis B," and published in Hepatology, a journal of the American Association for the Study of Liver Diseases.

6 Feb 2015

Breakthrough therapies for blood cancers may provide reasonable value for money spent

Amid the growing debate about the high price of powerful new drugs in the United States, a recent analysis suggests that breakthrough therapies for blood cancers may, in many cases and with some important caveats, provide reasonable value for money spent.

6 Feb 2015

Breakthrough blood cancer therapies may provide reasonable value for money spent

6 Feb 2015

Second opinions can optimize outcomes and avoid needless expenses

Mary Rockland was in a panic when she learned that she was diagnosed with invasive breast cancer. Like many patients, she trusted her doctor when he told her that a lump in her breast was cancerous, and relied on his judgment when he recommended a bilateral mastectomy.

6 Feb 2015

Asterias Biotherapeutics prices underwritten public offering of common stock at $3.90 per share

Asterias Biotherapeutics, Inc., a leading biotechnology company in the emerging field of regenerative medicine, today announced today that it has priced an underwritten public offering of its common stock at a price of $3.90 per share.

6 Feb 2015

MIT engineers discover way to grow liver-like cells to test potential malaria drugs

In 2008, the World Health Organization announced a global effort to eradicate malaria, which kills about 800,000 people every year. As part of that goal, scientists are trying to develop new drugs that target the malaria parasite during the stage when it infects the human liver, which is crucial because some strains of malaria can lie dormant in the liver for several years before flaring up.

6 Feb 2015

Prostate cancer patients with detectable post-operative PSA should receive more aggressive treatment

Prostate cancer patients with detectable prostate specific antigen (PSA) following radical prostatectomy should receive earlier, more aggressive radiation therapy treatment, according to a study published in the February 1, 2015 issue of the International Journal of Radiation Oncology * Biology * Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology.

6 Feb 2015

New report explores measures to address shortages of lifesaving medicines

As shortages of lifesaving medicines, including antibiotics, chemotherapy, and cardiovascular drugs continue to plague the United States, a group of health care organizations released a report exploring measures that should be considered to address this ongoing issue. The report summarizes manufacturing, regulatory, and economic issues related to drug shortages, as well as potential solutions that were considered at a 2014 Summit attended by 22 stakeholder groups, including health care professionals and other non-profit organizations, industry, public interest, and government agencies.

6 Feb 2015

G1 Therapeutics receives $33 million in Series B funding to develop effective treatments for cancer

An RTP-based pharmaceutical company with roots at the University of North Carolina at Chapel Hill has received $33 million in Series B venture capital funding to develop more effective and less toxic methods to treat patients with cancer.

6 Feb 2015

ECOG-ACRIN Cancer Research Group opens clinical trial for women with newly diagnosed DCIS

In direct response to recommendations made by a National Institutes of Health scientific consensus panel, the ECOG-ACRIN Cancer Research Group announced today the opening of E4112, a clinical trial for women with newly diagnosed ductal carcinoma in situ (DCIS) of the breast who, together with their doctors, will use the results of a magnetic resonance imaging (MRI) exam to determine whether to undergo a lumpectomy or a mastectomy.

6 Feb 2015

New study links cell communication pathway to common brain tumors found in children

A new study by Johns Hopkins researchers links a well-known cell communication pathway called Notch to one of the most common -- but overall still rare -- brain tumors found in children.

6 Feb 2015

TrialReach raises $13.5M in Series B financing round

TrialReach, the world's largest provider of clinical trial information, today announced it has raised a $13.5M Series B financing round led by Smedvig Capital with participation from existing investors Amadeus Capital Partners and Octopus Investments. With one of the biggest digital health rounds ever raised in the United Kingdom, TrialReach plans to use the funds to support the growth of its clinical trial platform and expansion into the U.S..

6 Feb 2015

Crown Bioscience, NRCMM partner to develop new immune-oncology experimental cancer models

Crown Bioscience, Inc., a leading global drug discovery and development service company with its R&D centers across the globe has announced that a new partnership agreement has been reached with the National Resource Center for Mutant Mice and its commercial branch Nanjing Biotech Innovation Corporation, in Nanjing, Jiangsu Province, China.

6 Feb 2015

Cancer News and Research

Latest Cancer News and Research

Vanderbilt researchers find link between the biological clock and Angelman syndrome

Bright Pink and David's Bridal team up to educate women on breast and ovarian cancer

Study examines use of yoga therapy to address lymphedema

Study shows that text messages could improve skin cancer prevention, promote sun protection

Chemotherapy or immunosuppressive treatment may reactivate HBV

Breakthrough therapies for blood cancers may provide reasonable value for money spent

Breakthrough blood cancer therapies may provide reasonable value for money spent

Second opinions can optimize outcomes and avoid needless expenses

Asterias Biotherapeutics prices underwritten public offering of common stock at $3.90 per share

MIT engineers discover way to grow liver-like cells to test potential malaria drugs

Prostate cancer patients with detectable post-operative PSA should receive more aggressive treatment

New report explores measures to address shortages of lifesaving medicines

G1 Therapeutics receives $33 million in Series B funding to develop effective treatments for cancer

ECOG-ACRIN Cancer Research Group opens clinical trial for women with newly diagnosed DCIS

New study links cell communication pathway to common brain tumors found in children

TrialReach raises $13.5M in Series B financing round

Crown Bioscience, NRCMM partner to develop new immune-oncology experimental cancer models

Half of people in the UK will develop cancer, says new estimate

Isis receives $10 million from Biogen Idec to begin IND-supporting studies of ISIS-BIIB4 Rx

Newly found protein in naked mole rat helps ward off cancer

Cancer Research - Second Edition eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Newsletters you may be interested in